Comparison of effects of EPA and DHA in patients with type 2 diabetes
Phase 3
- Conditions
- Diabetes Mellitus 2.Non-insulin-dependent diabetes mellitus
- Registration Number
- IRCT138812102394N4
- Lead Sponsor
- Vice-chancellor for research, Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
1-Age: 35-65years;
2-Willing to participate;
3-Having diabetes type 2 for at least five years prior to entry;
4-Blood sugar control with biguanide and sulfonylurea drugs for at least of one year prior to entry;
5-Normal blood pressure and lipid profile;
6-BMI : 20-35 kg/m2;
Exclusion criteria:
1-Treatment with insulin;
2-Taking fish oil supplements or NSAIDs during the last 3 months before intervention;
3-Taking fish more than once a week;
4-Having cardiovascular, liver, kidney disease;
5-Smoking;
6-Weight changes more than three kilograms during three months before intervention;
7- Change in type or dose of oral hypoglycemic agent for at least two weeks prior to entry or during intervention;
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fasting blood sugar. Timepoint: at baseline, after 12 weeks. Method of measurement: enzymatic colorimetric.;Fat mass. Timepoint: at baseline, after 12 weeks. Method of measurement: BIA.;Malondialdehyde. Timepoint: at baseline, after 12 weeks. Method of measurement: ELISA.;C-reactive protein. Timepoint: at baseline, after 12 weeks. Method of measurement: ELISA.
- Secondary Outcome Measures
Name Time Method